Dublin, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/tz4tr7/global_depression)
has announced the addition of the "Global Depression Therapy & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast to 2020"
report to their offering.
Depression is a state of emotion that affects thoughts, actions and often, sleeping patterns of affected individual. Depression affects behavior in terms of loss of appetite, being in a constant state of despair, feeling disconnected with friends/family and disinterest in activities that were pleasurable earlier, and in extreme cases, depressive patient even contemplates and/or attempts self-harm such as suicide. Depression is a very common mental disorder and over 350 million patients of varied age groups suffer from this disease.
This report studies a number of facts based on the data collected over the years. Studies over the years suggest that females all over the world, are more susceptible to being diagnosed as clinically depressed. This report includes studies based on a wide geographical range observing the percentage of diagnosis recorded in various regions of the world in order to get a better understanding of this disease.
Geographically, North Africa and Middle Eastern countries have seen the highest prevalence rate of depression whereas North American countries have a moderate prevalence rate, while Japan has the lowest prevalence rate of depression. The report analyses the different market segments that exist here in the form of all possible treatments.
There are various methods to treat depression which include antidepressants drug therapies, various interpersonal therapies like Cognitive Behavior Therapy (CBT) and rational emotive behavior therapy (REBT), electroconvulsive therapy, psychodynamic therapy and therapies which involve use of neuro-technology and virtual reality. In the case of a situation where the patients do not respond to the existing treatments, 21st century and technological advancements have offered the possibility of specific devices that aid overcoming depression.
This report, in addition to addressing the existing therapies, also focuses on these devices- Fischer Wallace Stimulator, Transcranial Magnetic Stimulator, Deep Brain Stimulator, Virtual reality, Light Therapy, Vagus Nerve Simulator, Smart phone applications, Assistive technology. Other crucial topics relating with clinical depression that are covered in this report include distribution amongst different classes of population, antidepressants, generic & branded medicines, competitive intelligence, market analysis, market overview, determinants and segmentations (therapies) and also includes corporate profiling along with geographical analysis.
Key Topics Covered:
1. Depression Therapy
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Value Chain Analysis
3.3. Key Buying Criteria
3.4. Strategic Recommendation
4. Market Determinants
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
5. Market Segmentation
5.1. Types of depression therapies
5.2. Types of antidepressants
5.3. Mental health devices
6. Special Conditions
6.1. Antidepressant discontinuation syndrome
6.2. Treatment resistant depression
6.3. Depression in men
6.4. Depression in women
6.5. Depression in elderly
7. Depression treatment centers and rehabilitation centers
8. Generic medicines vs. Branded medicines
9. Competitive Intelligence
10. Market Share Analysis
11. Geography Analysis
11.1. North America
11.2. Europe
11.3. Asia Pacific
11.4. RoW
12. Corporate Profiling
12.1. Pfizer
12.2. GlaxoSmithKline
12.3. Forest Labs
12.4. SunPharma
12.5. Eli lily and company
12.6. Mayo Clinic
12.7. Neurostar
12.8. Brainsway
12.9. Fisher Wallace
12.10. MagVanture
For more information visit http://www.researchandmarkets.com/research/tz4tr7/global_depression